Stem cell shot aims to heal kidneys fast

NCT ID NCT06954740

Recruiting now Disease control Sponsor: Chinese PLA General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 15, 2026 · Updated 2 times

Summary

This study tests whether Amimestrocel, a stem cell therapy from umbilical cords, can help people with acute kidney injury. Fifty adults aged 18 to 75 will receive the cells through an IV on four days. Researchers will check kidney function and safety over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Amimestrocel (stem cells from umbilical cord)
What this could lead to: If it works, this could point toward a new treatment to help kidneys recover faster after acute injury.
What could go wrong: This is an early Phase 2 trial with only 50 people, so results may not apply broadly. Stem cell treatments can have unknown side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute kidney injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE KIDNEY INJURY

Contacts and locations

Locations

Beijing Tsinghua Changgung Hospital, Medical Center, Tsinghua University
NOT_YET_RECRUITING

Beijing, Beijing Municipality, China
Beijing hospital
RECRUITING

Beijing, Beijing Municipality, 100010, China
Capital Medical University Affiliated Beijing Friendship Hospital
RECRUITING

Beijing, Beijing Municipality, 100050, China
China-Japan Friendship Hospital
RECRUITING

Beijing, Beijing Municipality, 100029, China
Chinese PLA General Hospital
RECRUITING

Beijing, Beijing Municipality, 100853, China
Xuanwu Hospital, Capital Medical University
RECRUITING

Beijing, Beijing Municipality, 100053, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.